Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients

By sjmartinez • July 12, 2024

Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 Jun 29;68:152504. doi: 10.1016/j.semarthrit.2024.152504. Epub ahead of print. PMID: 38991379.

Tags: biological therapy, cardiovascular diseases, lipoprotein, Publications, Rheumatoid arthritis, Rheumatology

Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review

Sarmadian PJ, Pirooz AD, Al Baghdadi M, Kamgar M, Afshar Y, Nobakht N. Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A[...]

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová[...]

Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy

Carlson SG, Puliafito BR, Kawai K, Senaratne TN, Lee TD, Lin T, Timmerman J, Larson SM. Impact of clonal hematopoiesis of indeterminate potential on treatment[...]